Katarzyna Fojcik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katarzyna Fojcik has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anna Mazur
Medical University of Silesia
4 shared publications - Julia Brodziak
Medical University of Silesia
4 shared publications - Marta Kowalska
Medical University of Silesia
4 shared publications - Mateusz Matyja
Wojewódzki Szpital Specjalistyczny nr 5 w Sosnowcu
4 shared publications - Michał Dworak
Medical University of Silesia
4 shared publications - Tomasz Wiśniewski
Medical University of Silesia
4 shared publications
Latest Publications
- Open Access
- 31 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68181
Topical niacinamide in the management of melasma and facial hyperpigmentation – a narrative review
Background: Melasma is a common facial hyperpigmentation condition and has an impact on patients’ quality of life. This and other facial hyperpigmentation disorders are common problems in women of reproductive age. The standard of care remains topical hydroquinone, often combined with a retinoid and a corticosteroid. However, its long-term use is associated with a risk of irritation, paradoxical hypopigmentation and exogenous ochronosis. Niacinamide is a well-established dermocosmetic ingredient with anti-inflammatory, antioxidant, barrier-protective and depigmenting properties. Aim: To summarise current knowledge on the mechanisms of action of niacinamide in the regulation of skin pigmentation and to review clinical studies on topical niacinamide in melasma and other facial hyperpigmentation disorders. Material and methods: A review of the literature was conducted in PubMed, PubMed Central and Google Scholar from 2015 to 2025. The articles were included if they were full-text original reviews and addressed topical niacinamide use. Results: Topical 4% niacinamide demonstrated efficacy comparable to 4% hydroquinone. The advantages are better tolerability, less erythema and dryness, and no reports of ochronosis. Niacinamide acts mainly by inhibiting melanosome transfer, modulating oxidative stress and the inflammatory response. Combinations of niacinamide with other depigmenting agents and procedural interventions, like laser therapy, microneedling or chemical peels, were effective in melasma, post-inflammatory acne hyperpigmentation, and photoaging. It is a safe alternative to hydroquinone-containing preparations. Conclusions: Topical niacinamide is a safe and versatile depigmenting agent with a pleiotropic mechanism of action. It should be considered an important component of modern treatment algorithms for facial hyperpigmentation, both as an alternative to hydroquinone and as a key element of combination and maintenance regimens.
- 31 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68181
Open AccessTopical niacinamide in the management of melasma and facial hyperpigmentation – a narrative review
Background: Melasma is a common facial hyperpigmentation condition and has an impact on patients’ quality of life. This and other facial hyperpigmentation disorders are common problems in women of reproductive age. The standard of care remains topical hydroquinone, often combined with a retinoid and a corticosteroid. However, its long-term use is associated with a risk of irritation, paradoxical hypopigmentation and exogenous ochronosis. Niacinamide is a well-established dermocosmetic ingredient with anti-inflammatory, antioxidant, barrier-protective and depigmenting properties. Aim: To summarise current knowledge on the mechanisms of action of niacinamide in the regulation of skin pigmentation and to review clinical studies on topical niacinamide in melasma and other facial hyperpigmentation disorders. Material and methods: A review of the literature was conducted in PubMed, PubMed Central and Google Scholar from 2015 to 2025. The articles were included if they were full-text original reviews and addressed topical niacinamide use. Results: Topical 4% niacinamide demonstrated efficacy comparable to 4% hydroquinone. The advantages are better tolerability, less erythema and dryness, and no reports of ochronosis. Niacinamide acts mainly by inhibiting melanosome transfer, modulating oxidative stress and the inflammatory response. Combinations of niacinamide with other depigmenting agents and procedural interventions, like laser therapy, microneedling or chemical peels, were effective in melasma, post-inflammatory acne hyperpigmentation, and photoaging. It is a safe alternative to hydroquinone-containing preparations. Conclusions: Topical niacinamide is a safe and versatile depigmenting agent with a pleiotropic mechanism of action. It should be considered an important component of modern treatment algorithms for facial hyperpigmentation, both as an alternative to hydroquinone and as a key element of combination and maintenance regimens.
- Open Access
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
The impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessThe impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- Open Access
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
The impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- 3 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessThe impact of obesity on clinical outcomes in acute pancreatitis: a systematic review
Background: Obesity may influence the severity of acute pancreatitis (AP) by intensifying inflammatory and metabolic disturbances. However, evidence is inconsistent due to differences in patient characteristics and AP causes. Clarification is needed to determine if obesity reliably predicts severe AP and complications. Aim:To evaluate the association between obesity, disease severity, complications, and clinical outcomes in AP. Methods: We conducted a systematic review of observational studies following PRISMA guidelines. We searched databases for studies on adult AP patients assessing obesity or BMI in relation to disease severity, organ failure, local complications, ICU admission, or mortality. We excluded studies on visceral adiposity indices only, pediatric cohorts, non-original publications, and non-RCT/non-observational designs. Results: Eleven studies met the inclusion criteria. Most reported that obesity is linked with increased AP severity and higher rates of systemic or local complications, such as organ failure, necrosis, and greater healthcare utilization. Large database studies confirmed increased complication rates in obese patients. However, findings regarding mortality were inconsistent: some studies noted higher mortality in overweight individuals, others showed no difference. Studies using BMI as a continuous variable found a consistent association between higher BMI and increased AP severity. Conclusions: Obesity appears to be associated with more severe AP and selected complications, but its link to mortality remains unclear. BMI alone shows limited predictive value and should be interpreted alongside other clinical data. Further research is required to standardize the incorporation of obesity into early AP risk assessment.
- Open Access
- 6 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47
Rhinitis in Swimmers: A Clinical Issue at the Intersection of Sports Medicine and Otorhinolaryngology
The development of rhinitis in swimmers is multifactorial. Contact with disinfection byproducts plays a role in the pathogenesis of swimmer's rhinitis, leading to irritation, increased epithelial permeability, and the development of mucosal hyperreactivity, which promotes the dominance of the non-allergic irritant rhinitis phenotype in competitive swimmers. A significant deterioration in quality of life has been demonstrated in swimmers with rhinitis, as assessed using validated scales, in particular the miniRQLQ. The review emphasises the role of chronic exposure to the swimming pool environment as a modifiable risk factor and indicates that limiting contact with irritants – through the use of swimming clips, optimising ventilation, and improving water quality – can lead to reduced symptom severity and partial reversibility of changes in the nasal mucosa. Attention was drawn to the significant heterogeneity in definitions and diagnostic criteria in the literature, which makes it difficult to assess the disease's prevalence and mechanisms clearly.
- 6 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 47
Open AccessRhinitis in Swimmers: A Clinical Issue at the Intersection of Sports Medicine and Otorhinolaryngology
The development of rhinitis in swimmers is multifactorial. Contact with disinfection byproducts plays a role in the pathogenesis of swimmer's rhinitis, leading to irritation, increased epithelial permeability, and the development of mucosal hyperreactivity, which promotes the dominance of the non-allergic irritant rhinitis phenotype in competitive swimmers. A significant deterioration in quality of life has been demonstrated in swimmers with rhinitis, as assessed using validated scales, in particular the miniRQLQ. The review emphasises the role of chronic exposure to the swimming pool environment as a modifiable risk factor and indicates that limiting contact with irritants – through the use of swimming clips, optimising ventilation, and improving water quality – can lead to reduced symptom severity and partial reversibility of changes in the nasal mucosa. Attention was drawn to the significant heterogeneity in definitions and diagnostic criteria in the literature, which makes it difficult to assess the disease's prevalence and mechanisms clearly.